DALLAS, Oct. 4, 2011 /PRNewswire/ -- Goldfarb Branham LLP
is investigating whether the board of directors of Pharmaceutical
Product Development (NASDAQ: PPDI) violated shareholder protection
laws by agreeing to sell the company for $33.25 per share. Concerned investors are
encouraged to contact attorney Hamilton Lindley at 877-583-2855 or
hlindley@goldfarbbranham.com about their rights and remedies.
"As recently as mid-August, shares of the company were trading
at $32.20 per share," securities
lawyer Hamilton Lindley said. "Additionally, at least one
analyst set a target price of $38.00
per share on the PPDI stock. Our proposed shareholder class
action lawsuit seeks to ensure that investors get the most value
for their stock in this buyout."
Goldfarb Branham LLP lawyers have significant experience
representing shareholders and whistleblowers in securities lawsuits
nationwide. Pharmaceutical Product Development stockholders – or
anyone with knowledge about this acquisition – should contact
lawyer Hamilton Lindley at hlindley@goldfarbbranham.com or
877-583-2855.
Hamilton Lindley
Goldfarb Branham LLP
2501 N. Harwood, Ste. 1801
Dallas, TX 75201
(877) 583-2855 Toll Free Telephone
(214) 583-2233 Local Phone Number
(214) 583-2234 Fax Number
hlindley@goldfarbbranham.com
www.goldfarbbranham.com
SOURCE Goldfarb Branham LLP